ALB and Cognitive impairment: Furthermore, antibodies in serum as well as further CSF/serum markers for BBBd (ideally, not only CSF/serum albumin quotient but also additional markers such as for example S100 isoforms) should be measured prospectively to test for possible mechanisms of emergence of cognitive deficits in CADP patients.